Biomarkers for assessing peripheral neuropathy response to cancer treatment
Abstract:
The present invention provides methods for identifying patients at increased risk of developing an adverse neurological event in response to a cancer treatment. Methods also include modifying the treatment regimen of said patent dependent on the presence or absence of biomarkers in the patient.
Information query
Patent Agency Ranking
0/0